iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. ...Middle East

PR Newswire - Economy
Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoids The first target cancer type of PHAGERIA® technology is colorectal cancer (CRC) BOSTON and SEOUL, South Korea, April 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",...

Hence then, the article about intron confirms cancer controlling effect of phageria drug candidate in the organoid model was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. )

Apple Storegoogle play

Last updated :

Also on site :



Latest News